WATCH: Trump's Broken Promises on Prescription Drugs
Senate Committee on Finance · February 5, 2026
At a Senate Committee on Finance event, senators pressed for stronger prescription drug pricing reforms, touted recent PBM transparency rules, and criticized the administration's engagements with pharmaceutical companies; they discussed Medicare negotiation, reference pricing, and Most-Favored-Nation deals, and took questions from reporters but recorded no votes or formal actions.
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.
No transcript available.
No outline available for this source.
No related articles available for this source.
No highlights available for this source.
No claims available for this source.
No actions available for this source.
No topics available for this source.
No clarifying details available for this source.
No discussions available for this source.
No community relevance data available for this source.
No funding sources available for this source.
No speakers available for this source.
No transcript available for this source.